about
ADAMTS-12 metalloprotease is necessary for normal inflammatory responseClinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognitionDNA methylation dynamics in blood after hematopoietic cell transplant.Effects of Estrogen and Phytoestrogen Treatment on an In Vitro Model of Recurrent Stroke on HT22 Neuronal Cell Line.Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response.The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment.Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma.Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC).Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty.MMP-25 Metalloprotease Regulates Innate Immune Response through NF-κB Signaling.Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia.Diagnostic screening of paroxysmal nocturnal hemoglobinuria: Prospective multicentric evaluation of the current medical indications.Correction: DNA Methylation Dynamics in Blood after Hematopoietic Cell Transplant.Loss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating IGF-1 signaling.Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis.NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.Non-coding recurrent mutations in chronic lymphocytic leukaemiaMutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcomeBasophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapyMutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaChromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment.ADAMTS-12 metalloprotease is necessary for normal inflammatory response.Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive the[Diagnosis and treatment of nocturnal paroxysmal hemoglobinuria]Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant[Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria]Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromeMultiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myelomaFlow cytometry diagnosis in myelodysplastic syndrome: Current practice in Latin America and comparison with other regions of the worldDevelopment of an algorithm for the identification of leukemic hematolymphoid neoplasms in Primary Care patientsExpression of CD47 antigen in Reed-Sternberg cells as a new potential biomarker for classical Hodgkin lymphoma
P50
Q24299706-819F3108-CD08-4285-A9E3-F827251DEE6DQ27853333-DE938031-D351-4F1D-8BC2-09AEE90A30B1Q33761979-2EEB74E7-F429-48BA-8652-DC7BD38A035EQ34602752-E286988B-597E-4543-92B9-08DFAC1E89FFQ38779731-0B3502BA-91A4-4154-92E6-CDB5C64E8156Q39590174-0F92AF1C-9FDD-420B-ADEB-93B64274B3EDQ40095812-5C8EF025-5D67-48A7-92E4-BD0F590BB9FAQ42537560-B518DC54-37E2-432E-9505-17CABC0580D9Q44004521-E4D8C6F6-FE1D-4006-BAF3-4BA6DDFF1876Q45323385-A94C7E9E-B1F7-48BE-81CA-B031FEA149D5Q46859906-EE19827B-EBE9-45CB-8489-FE5E2DF06469Q47608788-D5A13F43-29C2-485F-B4F2-8EF955A5C39BQ48213244-3ABA8272-B0A6-4C00-9E21-CFA8CDB8E212Q48326934-07275ACB-6B2A-4D33-A271-97B02A769990Q48344209-77AEB110-68A4-4095-A2D6-C42C0BAC77EFQ48800125-E5E6F43C-33B5-44D8-89F3-8DF58E79B23EQ50048642-ADF7DFA4-AA1F-4B6F-96A9-DF620FFE0877Q50236752-F0EC36B8-88AD-40CD-A2E5-D8B01A1C8475Q50492462-016DFC8F-22A9-4FA1-B451-56C998F19A61Q53259951-7CB49C76-09F2-4F9C-BF01-4F7270CD1D69Q56996904-CD030F29-B6F8-42CD-B235-7949FCA64998Q57082594-8AB11711-CF0C-446F-8B4A-D75342041182Q57173152-7EEA1DAB-3E92-470F-9CB8-7263E925BEE0Q64077384-B6C90897-599E-4E17-8710-1DF67A144E76Q64921703-C712458C-3BE2-4C66-A982-B7169A676153Q64951811-1A58F5EA-5C84-4731-88A3-F6A49793A9F3Q82006493-8BD39FF6-5950-4310-9861-02E3EAD1FE6DQ82447695-0FCC0E9B-7D2B-464D-B54F-5997B2811E1FQ82931329-639E06D6-F1A3-4B15-9C54-41D675ABFEAEQ87327643-86EAC786-EF45-45FE-AC8D-1BB82D20DC11Q87491377-5442E6F8-D9A2-433F-B879-FC5BA8196D6FQ87982213-FDE500AB-4479-481B-8648-539088A421C1Q91655207-E9E3F54B-D6EA-401C-844F-F9848BB78256Q91873938-365471E6-8CA6-4CB3-8AEA-76786DDA2632Q92269806-64BD041C-39CA-4FAE-AFAE-C34C1FBDDED3
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Enrique Colado
@ast
Enrique Colado
@en
Enrique Colado
@es
Enrique Colado
@nl
Enrique Colado
@sl
type
label
Enrique Colado
@ast
Enrique Colado
@en
Enrique Colado
@es
Enrique Colado
@nl
Enrique Colado
@sl
prefLabel
Enrique Colado
@ast
Enrique Colado
@en
Enrique Colado
@es
Enrique Colado
@nl
Enrique Colado
@sl
P106
P21
P31
P496
0000-0001-8675-8207